129 related articles for article (PubMed ID: 38297870)
1. [Analysis of Delphain lymph node detection rate, metastasis rate and risk factors for metastasis in papillary thyroid adenocarcinoma patients].
Xin Y; Sun X; Shang X; Xu G; Liu Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Feb; 38(2):150-154;159. PubMed ID: 38297870
[No Abstract] [Full Text] [Related]
2. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis.
Zhao J; Zhang Y; Zheng X
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):635-638. PubMed ID: 35210104
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.
Ni Y; Wang T; Wang X; Tian Y; Wei W; Liu Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):225-232. PubMed ID: 36161301
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma.
Oh EM; Chung YS; Lee YD
World J Surg; 2013 Nov; 37(11):2594-9. PubMed ID: 23877804
[TBL] [Abstract][Full Text] [Related]
5. The significance of Delphian lymph node in papillary thyroid cancer.
Tan Z; Ge MH; Zheng CM; Wang QL; Nie XL; Jiang LH
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e389-e393. PubMed ID: 26990889
[TBL] [Abstract][Full Text] [Related]
6. Integrating US-guided FNAB, BRAF
Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of Delphian lymph node metastasis in papillary thyroid cancer].
Zheng GB; Hao SL; Liu XC; Ning JY; Wu GC; Wang D; Li BY; Jiang LX; Song XC; Zheng HT
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Nov; 51(11):842-845. PubMed ID: 27938611
[No Abstract] [Full Text] [Related]
8. Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma.
Yan Y; Wang Y; Liu N; Duan Y; Chen X; Ye B; Yang R; Zhang W; Wang X
Eur J Surg Oncol; 2021 Jul; 47(7):1727-1733. PubMed ID: 33632590
[TBL] [Abstract][Full Text] [Related]
9. Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules.
Chen ML; Xu D; Yan XQ; Xie BJ
Asian J Surg; 2023 Jan; 46(1):156-159. PubMed ID: 35277319
[TBL] [Abstract][Full Text] [Related]
10. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer.
Li X; Duan Y; Liu D; Liu H; Zhou M; Yue K; Shuai Y; Wang Y; Ji C; Jing C; Wu Y; Wang X
Front Endocrinol (Lausanne); 2021; 12():591015. PubMed ID: 33841323
[TBL] [Abstract][Full Text] [Related]
12. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.
Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK
World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273
[TBL] [Abstract][Full Text] [Related]
13. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC?
Ma W; Guo Y; Hua T; Li L; Lv T; Wang J
Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400
[TBL] [Abstract][Full Text] [Related]
14. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
15. Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.
Liu WQ; Yang JY; Wang XH; Cai W; Li F
BMC Surg; 2022 Jun; 22(1):228. PubMed ID: 35701785
[TBL] [Abstract][Full Text] [Related]
16. Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma.
Sun H; Zhao X; Wang X; Ma J; Liu M
Diagn Pathol; 2024 Jan; 19(1):13. PubMed ID: 38218832
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
18. Use of Delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: A systematic review and meta-analysis.
Huang J; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T
Clin Endocrinol (Oxf); 2019 Jul; 91(1):170-178. PubMed ID: 30851206
[TBL] [Abstract][Full Text] [Related]
19. [Study on the relationship between ultrasonographic features of papillary thyroid carcinoma and central cervical lymph node metastasis].
Wang XQ; Wei W; Wei X; Xu Y; Wang HL; Xing XJ; Zhang S
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):196-200. PubMed ID: 29575838
[No Abstract] [Full Text] [Related]
20. Meta-analysis of the effect and clinical significance of Delphian lymph node metastasis in papillary thyroid cancer.
Chen Y; Wang Y; Li C; Zhang X; Fu Y
Front Endocrinol (Lausanne); 2023; 14():1295548. PubMed ID: 38313842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
